IGF1R_MOUSE - dbPTM
IGF1R_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID IGF1R_MOUSE
UniProt AC Q60751
Protein Name Insulin-like growth factor 1 receptor
Gene Name Igf1r
Organism Mus musculus (Mouse).
Sequence Length 1373
Subcellular Localization Cell membrane
Single-pass type I membrane protein.
Protein Description Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R (By similarity). When present in a hybrid receptor with INSR, binds IGF1 (By similarity)..
Protein Sequence MKSGSGGGSPTSLWGLVFLSAALSLWPTSGEICGPGIDIRNDYQQLKRLENCTVIEGFLHILLISKAEDYRSYRFPKLTVITEYLLLFRVAGLESLGDLFPNLTVIRGWKLFYNYALVIFEMTNLKDIGLYNLRNITRGAIRIEKNADLCYLSTIDWSLILDAVSNNYIVGNKPPKECGDLCPGTLEEKPMCEKTTINNEYNYRCWTTNRCQKMCPSVCGKRACTENNECCHPECLGSCHTPDDNTTCVACRHYYYKGVCVPACPPGTYRFEGWRCVDRDFCANIPNAESSDSDGFVIHDDECMQECPSGFIRNSTQSMYCIPCEGPCPKVCGDEEKKTKTIDSVTSAQMLQGCTILKGNLLINIRRGNNIASELENFMGLIEVVTGYVKIRHSHALVSLSFLKNLRLILGEEQLEGNYSFYVLDNQNLQQLWDWNHRNLTVRSGKMYFAFNPKLCVSEIYRMEEVTGTKGRQSKGDINTRNNGERASCESDVLRFTSTTTWKNRIIITWHRYRPPDYRDLISFTVYYKEAPFKNVTEYDGQDACGSNSWNMVDVDLPPNKEGEPGILLHGLKPWTQYAVYVKAVTLTMVENDHIRGAKSEILYIRTNASVPSIPLDVLSASNSSSQLIVKWNPPTLPNGNLSYYIVRWQRQPQDGYLYRHNYCSKDKIPIRKYADGTIDVEEVTENPKTEVCGGDKGPCCACPKTEAEKQAEKEEAEYRKVFENFLHNSIFVPRPERRRRDVMQVANTTMSSRSRNTTVADTYNITDPEEFETEYPFFESRVDNKERTVISNLRPFTLYRIDIHSCNHEAEKLGCSASNFVFARTMPAEGADDIPGPVTWEPRPENSIFLKWPEPENPNGLILMYEIKYGSQVEDQRECVSRQEYRKYGGAKLNRLNPGNYTARIQATSLSGNGSWTDPVFFYVPAKTTYENFMHLIIALPVAILLIVGGLVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMNRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEVEQNNLVLIPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTHSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIGSIKDEMEPSFQEVSFYYSEENKPPEPEELEMELEMEPENMESVPLDPSASSASLPLPERHSGHKAENGPGPGVLVLRASFDERQPYAHMNGGRANERALPLPQSSTC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
51N-linked_GlycosylationQQLKRLENCTVIEGF
HHHHHHCCCEEECCH
31.20-
102N-linked_GlycosylationSLGDLFPNLTVIRGW
HHHHHCCCCEEEECC
40.80-
135N-linked_GlycosylationIGLYNLRNITRGAIR
CEEEHHCCCCCCCEE
43.05-
245N-linked_GlycosylationSCHTPDDNTTCVACR
CCCCCCCCCEEEECC
44.67-
314N-linked_GlycosylationCPSGFIRNSTQSMYC
CCCCEEECCCCCEEE
44.59-
315PhosphorylationPSGFIRNSTQSMYCI
CCCEEECCCCCEEEE
20.2722871156
316PhosphorylationSGFIRNSTQSMYCIP
CCEEECCCCCEEEEE
28.3622871156
318PhosphorylationFIRNSTQSMYCIPCE
EEECCCCCEEEEECC
16.2922871156
418N-linked_GlycosylationGEEQLEGNYSFYVLD
CHHHHCCCEEEEEEC
21.65-
439N-linked_GlycosylationLWDWNHRNLTVRSGK
HHCCCCCCEEECCCC
32.29-
535N-linked_GlycosylationYKEAPFKNVTEYDGQ
EECCCCCCCEEECCC
46.45-
608N-linked_GlycosylationEILYIRTNASVPSIP
EEEEEECCCCCCCCC
21.99-
623N-linked_GlycosylationLDVLSASNSSSQLIV
CHHHCCCCCCCCEEE
45.70-
639N-linked_GlycosylationWNPPTLPNGNLSYYI
ECCCCCCCCCEEEEE
55.9119349973
641N-linked_GlycosylationPPTLPNGNLSYYIVR
CCCCCCCCEEEEEEE
32.2419349973
748N-linked_GlycosylationRDVMQVANTTMSSRS
HHHHHHHHHHCCCCC
36.9119656770
757N-linked_GlycosylationTMSSRSRNTTVADTY
HCCCCCCCCEECEEC
41.1519349973
765N-linked_GlycosylationTTVADTYNITDPEEF
CEECEECCCCCHHHH
32.5419349973
901N-linked_GlycosylationLNRLNPGNYTARIQA
CCCCCCCCCEEEEEE
32.0419656770
914N-linked_GlycosylationQATSLSGNGSWTDPV
EEEECCCCCCCCCCE
37.64-
974PhosphorylationRLGNGVLYASVNPEY
CCCCCEEEEECCHHH
8.409480911
981PhosphorylationYASVNPEYFSAADVY
EEECCHHHCCCCCEE
12.239480911
1024AcetylationGVAKGVVKDEPETRV
CHHHCCCCCCCCCEE
54.706568873
1034UbiquitinationPETRVAIKTVNEAAS
CCCEEEEEEHHHHHH
36.3622790023
1041PhosphorylationKTVNEAASMRERIEF
EEHHHHHHHHHHHHH
25.9723984901
1159PhosphorylationKIGDFGMTRDIYETD
EECCCCCCCEEEECC
26.1023375375
1163PhosphorylationFGMTRDIYETDYYRK
CCCCCEEEECCCCCC
19.648940173
1165PhosphorylationMTRDIYETDYYRKGG
CCCEEEECCCCCCCC
16.6022499769
1167PhosphorylationRDIYETDYYRKGGKG
CEEEECCCCCCCCCC
16.7625521595
1168PhosphorylationDIYETDYYRKGGKGL
EEEECCCCCCCCCCC
14.5225521595
1173UbiquitinationDYYRKGGKGLLPVRW
CCCCCCCCCCCCEEE
55.86-
1280PhosphorylationEPSFQEVSFYYSEEN
CCCCEEEEEEECCCC
13.5322685298
1282PhosphorylationSFQEVSFYYSEENKP
CCEEEEEEECCCCCC
9.8914963047
1283PhosphorylationFQEVSFYYSEENKPP
CEEEEEEECCCCCCC
13.9514963047
1284PhosphorylationQEVSFYYSEENKPPE
EEEEEEECCCCCCCC
27.3622685298
1319PhosphorylationDPSASSASLPLPERH
CCCCCCCCCCCCCCC
32.2525338131
1345PhosphorylationGVLVLRASFDERQPY
CEEEEEECCCCCCCC
27.1426824392
1352PhosphorylationSFDERQPYAHMNGGR
CCCCCCCCCCCCCCC
10.788940173
1370PhosphorylationRALPLPQSSTC----
CCCCCCCCCCC----
26.1925619855
1371PhosphorylationALPLPQSSTC-----
CCCCCCCCCC-----
28.6625619855
1372PhosphorylationLPLPQSSTC------
CCCCCCCCC------
27.7325521595

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
974YPhosphorylationKinaseIGF1RQ60751
PSP
974YPhosphorylationKinaseSRC64-PhosphoELM
974YPhosphorylationKinaseSRCP05480
PSP
981YPhosphorylationKinaseSRC64-PhosphoELM
981YPhosphorylationKinaseSRCP05480
PSP
981YPhosphorylationKinaseIGF1RQ60751
PSP
1163YPhosphorylationKinaseIGF1RQ60751
PSP
1163YPhosphorylationKinaseSRCP05480
PSP
1163YPhosphorylationKinaseSRC64-PhosphoELM
1167YPhosphorylationKinaseIGF1RQ60751
PSP
1167YPhosphorylationKinaseSRCP05480
PSP
1167YPhosphorylationKinaseSRC64-PhosphoELM
1168YPhosphorylationKinaseIGF1RQ60751
PSP
1168YPhosphorylationKinaseSRCP05480
PSP
1168YPhosphorylationKinaseSRC64-PhosphoELM
1280SPhosphorylationKinaseGSK3-BETAQ9WV60
Uniprot
1352YPhosphorylationKinaseIGF1RQ60751
PSP
1352YPhosphorylationKinaseSRCP05480
PSP
1352YPhosphorylationKinaseSRC64-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
29Kubiquitylation

-
48Kubiquitylation

-
1170Kubiquitylation

-
1173Kubiquitylation

-
1280SPhosphorylation

22685298
1284SPhosphorylation

22685298

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of IGF1R_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
GRB10_MOUSEGrb10physical
20980250
GRB10_MOUSEGrb10physical
9062339
IRS1_MOUSEIrs1physical
22033112

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of IGF1R_MOUSE

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.";
Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.;
Nat. Biotechnol. 27:378-386(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-639; ASN-641; ASN-757 ANDASN-765, AND MASS SPECTROMETRY.
"The mouse C2C12 myoblast cell surface N-linked glycoproteome:identification, glycosite occupancy, and membrane orientation.";
Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I.,Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E.,Wollscheid B.;
Mol. Cell. Proteomics 8:2555-2569(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-748 AND ASN-901, AND MASSSPECTROMETRY.

TOP